+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

From
From
From
From
From
From
From
Virtual Oncology - Global Strategic Business Report - Product Thumbnail Image

Virtual Oncology - Global Strategic Business Report

  • Report
  • June 2025
  • 364 Pages
  • Global
From
From
Cancer Biopsy Market Report 2025 - Product Thumbnail Image

Cancer Biopsy Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Clinical Nutrition for Cancer Care Market Report 2025 - Product Thumbnail Image

Clinical Nutrition for Cancer Care Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Interventional Oncology Devices Market Report 2025 - Product Thumbnail Image

Interventional Oncology Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Oncology Nutrition Market Report 2025 - Product Thumbnail Image

Oncology Nutrition Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Vulvar Cancer Global Market Report 2025 - Product Thumbnail Image

Vulvar Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Pancreatic Adenocarcinoma Treatment Global Market Report 2025 - Product Thumbnail Image

Pancreatic Adenocarcinoma Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Advanced Melanoma Global Market Report 2025 - Product Thumbnail Image

Advanced Melanoma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more